Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAS-102 with Radiotherapy in Elderly Esophageal Cancer
NCT07196345Phase 2Not yet recruiting
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Sep 2025
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trifluridine + tipiracil in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Shandong Provincial Qianfoshan Hospital. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
trifluridine + tipiracil
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT07196345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07196345.